Ganz, Tomas
Bino, Avi
Salusky, Isidro B.
Funding for this research was provided by:
Keryx Biopharmaceuticals, Inc.
Article History
First Online: 27 May 2019
Compliance with Ethical Standards
:
: TG is a scientific cofounder and shareholder of Intrinsic LifeSciences and Silarus Pharma. He is a consultant for Ablynx, Ambys, Akebia Therapeutics, Gilead, Global Blood Therapeutics, Keryx Biopharmaceuticals, La Jolla Pharmaceutical Company, Sierra Oncology and Vifor. He has received Grant support from Akebia Therapeutics and Keryx Biopharmaceuticals. AB was a consultant to Keryx and received support for characterizing the structural composition of Auryxia. IBS is a consultant for Akebia Therapeutics, Keryx Biopharmaceuticals, Amgen, and Ultragenyx. He has received Grant support from Amgen and AbbVie.
: Support was provided by Keryx Biopharmaceuticals, Inc., which is now a wholly owned subsidiary of Akebia Therapeutics, Inc.